To determine whether Sirt6 is causally related to the development of hepatic steatosis and its amelioration by RGZ, we directly inhibited Sirt6 by RNAi-mediated gene silencing in AML12 mouse hepatocytes. Here, SIRT6 is linked to fatty liver disease.